NCT03511235View on ClinicalTrials.gov

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

CompletedOBSERVATIONAL

Enrollment

774

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions

Prostate Cancer

Trial Locations (8)

10065

Memorial Sloane Kettering Cancer Center, New York

48109

University of Michigan Urology Cancer Center, Ann Arbor

63367

Dr. Jeffrey Glaser, Urologist, Lake Saint Louis

72211

Arkansas Urology, Little Rock

80907

Urological Associates, Colorado Springs

92868

Kar Urology, Orange

94114

Golden Gate Urology, San Francisco

94520

Pacific Urology, Concord

All Listed Sponsors

lead

Myriad Genetic Laboratories, Inc.

INDUSTRY

NCT03511235 - Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing | Biotech Hunter | Biotech Hunter